<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101525337</journal-id>
<journal-id journal-id-type="pubmed-jr-id">37346</journal-id>
<journal-id journal-id-type="nlm-ta">ACS Chem Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">ACS Chem Neurosci</journal-id>
<journal-title-group>
<journal-title>ACS chemical neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1948-7193</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30001118</article-id>
<article-id pub-id-type="pmc">6197894</article-id>
<article-id pub-id-type="doi">10.1021/acschemneuro.8b00155</article-id>
<article-id pub-id-type="manuscript">NIHMS982919</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine (MDMA)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dunlap</surname>
<given-names>Lee E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrews</surname>
<given-names>Anne M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1961-4833</contrib-id>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Olson</surname>
<given-names>David E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4517-0543</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Chemistry, University of California, Davis, Davis, CA 95616, USA</aff>
<aff id="A2"><label>2</label>Departments of Psychiatry and Chemistry &amp; Biochemistry, Semel Institute for Neuroscience and Human Behavior, and Hatos Center for Neuropharmacology, University of California, Los Angeles, CA 90095, USA</aff>
<aff id="A3"><label>3</label>Department of Biochemistry &amp; Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA</aff>
<aff id="A4"><label>4</label>Center for Neuroscience, University of California, Davis, Davis, CA 95616, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author Contributions</p>
<p id="P2">D.E.O. conceived the structure of the review. L.E.D. and D.E.O. wrote the manuscript with input from A.M.A. All authors edited the manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>17</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>10</issue>
<fpage>2408</fpage>
<lpage>2427</lpage>
<!--elocation-id from pubmed: 10.1021/acschemneuro.8b00155-->
<abstract id="ABS1">
<p id="P3">Better known as “ecstasy,” 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today’s teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science—having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract</title>
<p id="P4">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-982919-f0006.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>3,4-methylenedioxymethamphetamine</kwd>
<kwd>MDMA</kwd>
<kwd>psychedelic</kwd>
<kwd>entactogen</kwd>
<kwd>empathogen</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>